Cerebral Microangiopathy in Two Dogs with Cutaneous and Renal Glomerular Vasculopathy.

[1]  C. Mooney,et al.  Canine cutaneous and renal glomerular vasculopathy in the Republic of Ireland: a description of three cases , 2019, Irish Veterinary Journal.

[2]  Zini Gina,et al.  Diagnostic testing for differential diagnosis in Thrombotic Microangiopathies , 2019, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[3]  D. Walker,et al.  Dealing with cutaneous and renal glomerular vasculopathy in dogs , 2018, In Practice.

[4]  K. Stevens,et al.  Signalment risk factors for cutaneous and renal glomerular vasculopathy (Alabama rot) in dogs in the UK , 2018, Veterinary Record.

[5]  A. Swiatecka-Urban,et al.  Extra-renal manifestations of atypical hemolytic uremic syndrome , 2018, Pediatric Nephrology.

[6]  J. Moake,et al.  Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells , 2018, The Journal of Biological Chemistry.

[7]  A. Graham,et al.  Thrombotic Microangiopathies (TTP, HUS, HELLP). , 2017, Hematology/oncology clinics of North America.

[8]  P. Coppo,et al.  Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies , 2017, Journal of thrombosis and haemostasis : JTH.

[9]  C. Couto,et al.  Cutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK , 2015, Veterinary Record.

[10]  L. Pallardó,et al.  Remission of aHUS neurological damage with eculizumab , 2015, Clinical kidney journal.

[11]  J. Hofer,et al.  Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies , 2014, Frontiers in Pediatrics.

[12]  S. Cohney,et al.  Thrombotic microangiopathy and associated renal disorders , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  G. Remuzzi,et al.  Thrombotic microangiopathies: from animal models to human disease and cure. , 2011, Contributions to nephrology.

[14]  K. Amann,et al.  Thrombotic microangiopathy: new insights , 2010, Current opinion in nephrology and hypertension.

[15]  H. Tsai.  Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency. , 2007, Hematology/oncology clinics of North America.

[16]  A. Cataldi,et al.  Shiga toxin-producing and attaching and effacing Escherichia coli in cats and dogs in a high hemolytic uremic syndrome incidence region in Argentina. , 2007, FEMS microbiology letters.

[17]  F. Udaka,et al.  MRI demonstration of a reversible lesion in cerebral deep white matter in thrombotic thrombocytopenic purpura , 1996, Neuroradiology.

[18]  A. Howie,et al.  Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome , 2004, Pediatric Nephrology.

[19]  J. Chantrey,et al.  Haemolytic-uraemic syndrome in a dog. , 2002, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.

[20]  D. Blumenthal,et al.  Neurologic manifestations of hematologic disorders. , 2002, Neurologic clinics.

[21]  B. Fenwick,et al.  Glomerular Ultrastructural Lesions of Idiopathic Cutaneous and Renal Glomerular Vasculopathy of Greyhounds , 1995, Veterinary pathology.

[22]  Shri K. Mishra.  Thrombotic Thrombocytopenic Purpura , 1985 .

[23]  A. Silverstein.  Thrombotic thrombocytopenic purpura. The initial neurologic manifestations. , 1968, Archives of neurology.